Song Mi Han

Title: Innovations of Song Mi Han in Transdermal Drug Delivery

Introduction

Song Mi Han is a notable inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of transdermal drug delivery systems. Her innovative work focuses on developing hydrogel resins that enhance the effectiveness of drug administration through the skin.

Latest Patents

Song Mi Han holds a patent for a "Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same." This invention relates to a UV-curable hydrogel resin designed for transdermal administration. The hydrogel prepared using this resin is particularly beneficial as it increases the water content of the hydrogel applied as a drug layer in a cataplasm. Additionally, it mitigates skin irritation and allows for the adjustment of crosslinking degrees for better adhesion control. This innovation is capable of controlling drug release properties and enhancing transdermal absorbability.

Career Highlights

Song Mi Han is currently associated with Icure Pharmaceutical Corp., where she continues to advance her research in drug delivery systems. Her work is pivotal in developing new methods for effective medication administration, which can significantly improve patient outcomes.

Collaborations

Some of her notable coworkers include Young Kweon Choi and Yong Ho Oh, who contribute to her research endeavors and innovations in the pharmaceutical field.

Conclusion

Song Mi Han's contributions to the field of transdermal drug delivery through her innovative hydrogel resin patent exemplify her commitment to advancing medical technology. Her work has the potential to greatly enhance the effectiveness of drug administration methods.